Telemedicine XR-B for Individuals in Jail

Part of paid clinical trials in Cumberland, Maryland.

Sponsor
Friends Research Institute, Inc.
Study ID
NCT07524738
Phase
PHASE3
Status
Active Not Recruiting

Conditions

  • Opioid Use Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Extended Release Buprenorphine — DRUG
    extended-release buprenorphine using telemedicine in jail

Study Details

This study is an open label pilot study of 30 incarcerated men and women receiving sublingual buprenorphine (SL-B) in jail who will voluntarily switch to extended-release buprenorphine (BRIXADI) using telemedicine prior to release. Individuals will receive weekly XR-B and at least one monthly XR-B injection prior to release. Individuals will be linked to a community treatment provider where they will continue their treatment (buprenorphine) post-release. Participants will be assessed at 1,2-, and 3-months post release

Key Dates

Start date
Jun 1, 2025
Status verified
Apr 2026
Primary completion
Jul 1, 2026
Completion
Sep 1, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: XR-B
    extended-release buprenorphine

Primary Outcome Measure

medication adherence [ Time Frame: three months post-release ]

Locations (1)

FacilityCityStateZIPSite coordinators
Allegany County Detention CenterCumberlandMaryland21502-

Find similar trials in Cumberland, MD

By research site
Allegany County Detention Center· Cumberland, MD

Related Studies